Geode Capital Management’s Iterum Therapeutics ITRM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.3K | Hold |
12,370
| – | – | ﹤0.01% | 4412 |
|
2025
Q1 | $15.2K | Hold |
12,370
| – | – | ﹤0.01% | 4399 |
|
2024
Q4 | $21.9K | Hold |
12,370
| – | – | ﹤0.01% | 4374 |
|
2024
Q3 | $13.5K | Buy |
+12,370
| New | +$13.5K | ﹤0.01% | 4441 |
|
2022
Q3 | – | Sell |
-92,095
| Closed | -$18K | – | 5035 |
|
2022
Q2 | $18K | Hold |
92,095
| – | – | ﹤0.01% | 4936 |
|
2022
Q1 | $32K | Buy |
92,095
+58,982
| +178% | +$20.5K | ﹤0.01% | 4891 |
|
2021
Q4 | $12K | Sell |
33,113
-96,158
| -74% | -$34.8K | ﹤0.01% | 4963 |
|
2021
Q3 | $72K | Buy |
129,271
+28,169
| +28% | +$15.7K | ﹤0.01% | 4732 |
|
2021
Q2 | $233K | Buy |
101,102
+4,929
| +5% | +$11.4K | ﹤0.01% | 4280 |
|
2021
Q1 | $135K | Buy |
96,173
+63,060
| +190% | +$88.5K | ﹤0.01% | 4229 |
|
2020
Q4 | $32K | Buy |
+33,113
| New | +$32K | ﹤0.01% | 4218 |
|